Cargando…
1ɑ,25‐Dihydroxyvitamin D(3) promotes osteogenesis by down‐regulating FGF23 in diabetic mice
1ɑ,25‐dihydroxyvitamin D3 (1,25D) and fibroblast growth factor 23 (FGF23) play important roles in bone metabolism through mutual regulation. However, the underlying mechanism between 1,25D and FGF23 in diabetes‐induced bone metabolism disorders has not yet been elucidated. In this study, we investig...
Autores principales: | Luo, Wenqiong, Jiang, Yixuan, Yi, Zumu, Wu, Yingying, Gong, Ping, Xiong, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051674/ https://www.ncbi.nlm.nih.gov/pubmed/33609082 http://dx.doi.org/10.1111/jcmm.16384 |
Ejemplares similares
-
1α,25-Dihydroxyvitamin D3 ameliorates diabetes-induced bone loss by attenuating FoxO1-mediated autophagy
por: Jiang, Yixuan, et al.
Publicado: (2021) -
1,25-Dihydroxyvitamin D(3) regulates furin-mediated FGF23 cleavage
por: Xie, Han, et al.
Publicado: (2023) -
Vitamin D, 1,25-Dihydroxyvitamin D, FGF23, and Graft Function after Renal Transplantation
por: Mehrotra, Sonia, et al.
Publicado: (2019) -
Single-cell RNA sequencing identifies Fgf23-expressing osteocytes in response to 1,25-dihydroxyvitamin D(3) treatment
por: Hanai, Ayako, et al.
Publicado: (2023) -
Serum FGF23 levels may not be associated with serum phosphate and 1,25-dihydroxyvitamin D levels in patients with Fanconi syndrome–induced hypophosphatemia
por: Goto, Shunsuke, et al.
Publicado: (2016)